Date Range
toReport Types
Condition
See all (35)
Region of the Body
See all (18)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
No clear benefit of liposomal bupivacaine over plain bupivacaine for periarticular injection in TKA
J Arthroplasty. 2018 Aug;33(8):2460-2464 doi: 10.1016/j.arth.2018.03.014
Higher cost & lack of analgesia benefit with liposomal bupivacaine vs bupivacaine/morphine
J Arthroplasty. 2016 Sep;31(9 Suppl):22-5
No significant analgesic benefit of liposomal bupivacaine over bupivacaine HCl for PAI in TJA
J Arthroplasty. 2017 Feb;32(2):628-634
No analgesic advantage of liposomal bupivacaine over ropivacaine for infiltration analgesia in TKA
J Arthroplasty. 2018 Aug;33(8):2455-2459. doi: 10.1016/j.arth.2018.02.083
Liposomal bupivacaine vs. bupivacaine: same analgesic efficacy and narcotic use after TKA
J Arthroplasty. 2015 Sep;30(9 Suppl):64-7
TKA: liposomal bupivacaine vs. standard periarticular injection in chronic opioid users
J Arthroplasty. 2016 Aug;31(8):1702-5
Postoperative analgesia with liposomal bupivacaine vs. bupivacaine HCl in outpatient ACLR
Am J Sports Med. 2016 Jul;44(7):1680-6
Comparing PAI liposomal bupivacaine and ISBPB for postoperative analgesia following TSA
J Bone Joint Surg Am. 2017 Apr 5;99(7):550-556
Influences of route of acetaminophen administration and periarticular liposomal bupivacaine in TKA
J Arthroplasty. 2018 Jul;33(7S):S136-S141. doi: 10.1016/j.arth.2018.02.088
Lumbar plexus block vs periarticular infiltration with ropivacaine or liposomal bupivacaine in THA
J Bone Joint Surg Am. 2017 Nov 1;99(21):1836-1845
Liposomal bupivacaine vs Ranawat suspension injection for postoperative pain after TKA
J Arthroplasty. 2016 Mar;31(3):633-6.
Efficacy and safety of liposomal bupivacaine injection vs continuous ISB for shoulder arthroplasty
J Shoulder Elbow Surg. 2017 Oct;26(10):1810-1817
Similar clinical outcomes between PAI with liposomal bupivacaine and continuous FNB following TKA
J Arthroplasty. 2019 Mar;34(3):495-500.